Oncology Journals

CC

Ca-a Cancer Journal For Clinicians

WILEY

IF: 232.4

Q1

Hybrid

Oncology

IF: 232.4

Q1

Hybrid

NR

Nature Reviews Clinical Oncology

NATURE PORTFOLIO

IF: 82.2

Q1

Hybrid

Oncology

IF: 82.2

Q1

Hybrid

NR

Nature Reviews Cancer

NATURE PORTFOLIO

IF: 66.8

Q1

Hybrid

Oncology

IF: 66.8

Q1

Hybrid

AO

Annals Of Oncology

Elsevier BV

IF: 65.4

Q1

Hybrid

Oncology

IF: 65.4

Q1

Hybrid

CC

Cancer Cell

CELL PRESS

IF: 44.5

Q1

Hybrid

Oncology

IF: 44.5

Q1

Hybrid

JO

Journal Of Clinical Oncology

LIPPINCOTT WILLIAMS & WILKINS

IF: 41.9

Q1

Hybrid

Oncology

IF: 41.9

Q1

Hybrid

JO

Journal Of Hematology & Oncology

BioMed Central

IF: 40.4

Q1

Open

Hematology

Oncology

IF: 40.4

Q1

Open

LO

Lancet Oncology

Elsevier BV

IF: 35.9

Q1

Hybrid

Oncology

IF: 35.9

Q1

Hybrid

MC

Molecular Cancer

BioMed Central

IF: 33.9

Q1

Open

Oncology

IF: 33.9

Q1

Open

CD

Cancer Discovery

American Association for Cancer Research

IF: 33.3

Q1

Closed

Oncology

IF: 33.3

Q1

Closed

NC

Nature Cancer

NATURE PORTFOLIO

IF: 28.5

Q1

Hybrid

Oncology

IF: 28.5

Q1

Hybrid

CC

Cancer Communications

WILEY

IF: 24.9

Q1

Open

Oncology

IF: 24.9

Q1

Open

JO

Journal Of Thoracic Oncology

Elsevier BV

IF: 20.8

Q1

Hybrid

Oncology

Respiratory

IF: 20.8

Q1

Hybrid

JO

JAMA Oncology

American Medical Association

IF: 20.1

Q1

Closed

Oncology

IF: 20.1

Q1

Closed

TI

Trends In Cancer

Elsevier BV

IF: 17.5

Q1

Hybrid

Oncology

IF: 17.5

Q1

Hybrid

CR

Cancer Research

American Association for Cancer Research

IF: 16.6

Q1

Open

Oncology

IF: 16.6

Q1

Open

JO

Journal Of The National Comprehensive Cancer Network

National Comprehensive Cancer

IF: 16.4

Q1

Closed

Oncology

IF: 16.4

Q1

Closed

SI

Seminars In Cancer Biology

Elsevier BV

IF: 15.7

Q1

Hybrid

Oncology

IF: 15.7

Q1

Hybrid

EH

Experimental Hematology & Oncology

BioMed Central

IF: 13.5

Q1

Open

Hematology

Oncology

IF: 13.5

Q1

Open

Le

Leukemia

Springer Nature

IF: 13.4

Q1

Hybrid

Hematology

Oncology

IF: 13.4

Q1

Hybrid

Ne

Neuro-oncology

Oxford University Press

IF: 13.4

Q1

Hybrid

Neurology

Oncology

IF: 13.4

Q1

Hybrid

JC

Jacc: Cardiooncology

Elsevier BV

IF: 12.8

Q1

Open

Cardiology

Oncology

IF: 12.8

Q1

Open

JO

Journal Of Experimental & Clinical Cancer Research

BioMed Central

IF: 12.8

Q1

Open

Oncology

IF: 12.8

Q1

Open

BC

Blood Cancer Journal

Springer Nature

IF: 11.6

Q1

Open

Hematology

Oncology

IF: 11.6

Q1

Open

BC

Blood Cancer Discovery

American Association for Cancer Research

IF: 11.5

Q1

Hybrid

Hematology

Oncology

IF: 11.5

Q1

Hybrid

BR

Biomarker Research

BioMed Central

IF: 11.5

Q1

Open

Research

Oncology

IF: 11.5

Q1

Open

JF

Journal For Immunotherapy Of Cancer

BMJ

IF: 10.6

Q1

Open

Immunology

Oncology

IF: 10.6

Q1

Open

CT

Cancer Treatment Reviews

Elsevier BV

IF: 10.5

Q1

Hybrid

Oncology

IF: 10.5

Q1

Hybrid

CC

Clinical Cancer Research

American Association for Cancer Research

IF: 10.2

Q1

Closed

Oncology

IF: 10.2

Q1

Closed

CL

Cancer Letters

Elsevier BV

IF: 10.1

Q1

Hybrid

Oncology

IF: 10.1

Q1

Hybrid

JO

Journal Of The National Cancer Center

Elsevier BV

IF: 9.4

Q1

Open

Oncology

IF: 9.4

Q1

Open

EU

European Urology Oncology

Elsevier BV

IF: 9.3

Q1

Hybrid

Oncology

Urology

IF: 9.3

Q1

Hybrid

LC

Liver Cancer

Karger Publishers

IF: 9.1

Q1

Hybrid

Gastroenterology

Oncology

IF: 9.1

Q1

Hybrid

CA

Cancer And Metastasis Reviews

Springer Science+Business Media

IF: 8.7

Q1

Hybrid

Oncology

IF: 8.7

Q1

Hybrid

CB

Cancer Biology & Medicine

Chinese Anti-Cancer Association

IF: 8.4

Q1

Open

Research

Oncology

IF: 8.4

Q1

Open

EO

Esmo Open

Elsevier BV

IF: 8.3

Q1

Open

Oncology

IF: 8.3

Q1

Open

BE

Biochimica Et Biophysica Acta-reviews On Cancer

Elsevier BV

IF: 8.3

Q1

Hybrid

Oncology

IF: 8.3

Q1

Hybrid

NP

Npj Precision Oncology

NATURE PORTFOLIO

IF: 8

Q1

Open

Oncology

IF: 8

Q1

Open

Br

Breast

Elsevier BV

IF: 7.9

Q1

Open

OB/GYN

Oncology

IF: 7.9

Q1

Open

Ne

Neoplasia

Elsevier BV

IF: 7.7

Q1

Open

Oncology

IF: 7.7

Q1

Open

NB

Npj Breast Cancer

NATURE PORTFOLIO

IF: 7.6

Q1

Open

Oncology

IF: 7.6

Q1

Open

JO

Jnci-journal Of The National Cancer Institute

Oxford University Press

IF: 7.2

Q1

Hybrid

Oncology

IF: 7.2

Q1

Hybrid

EJ

European Journal Of Cancer

Elsevier BV

IF: 7.1

Q1

Closed

Oncology

IF: 7.1

Q1

Closed

Bi

Biodrugs

Adis, Springer Healthcare

IF: 6.9

Q1

Hybrid

Immunology

Oncology

Pharmacology

IF: 6.9

Q1

Hybrid

CA

Clinical And Translational Medicine

Springer Science+Business Media

IF: 6.8

Q1

Open

Research

Oncology

IF: 6.8

Q1

Open

BJ

British Journal Of Cancer

Springer Nature

IF: 6.8

Q1

Hybrid

Oncology

IF: 6.8

Q1

Hybrid

IJ

International Journal Of Radiation Oncology Biology Physics

Elsevier BV

IF: 6.5

Q1

Hybrid

Oncology

Radiology

IF: 6.5

Q1

Hybrid

On

Oncoimmunology

Landes Bioscience

IF: 6.3

Q1

Open

Immunology

Oncology

IF: 6.3

Q1

Open

CC

Cancer Cell International

BioMed Central

IF: 6

Q1

Open

Oncology

IF: 6

Q1

Open

CR

Critical Reviews In Oncology Hematology

Elsevier BV

IF: 5.6

Q1

Hybrid

Hematology

Oncology

IF: 5.6

Q1

Hybrid

BC

Breast Cancer Research

BioMed Central

IF: 5.6

Q1

Open

Oncology

IF: 5.6

Q1

Open

MC

Molecular Cancer Therapeutics

American Association for Cancer Research

IF: 5.5

Q1

Closed

Oncology

IF: 5.5

Q1

Closed

RA

Radiotherapy And Oncology

Elsevier BV

IF: 5.3

Q1

Hybrid

Oncology

Radiology

IF: 5.3

Q1

Hybrid

JO

Journal Of Pathology

WILEY

IF: 5.2

Q1

Hybrid

Oncology

Pathology

IF: 5.2

Q1

Hybrid

BM

Bone Marrow Transplantation

Springer Nature

IF: 5.2

Q1

Hybrid

Hematology

Immunology

Oncology

Transplantation

IF: 5.2

Q1

Hybrid

CI

Cancer Immunology Immunotherapy

Springer Science+Business Media

IF: 5.1

Q1

Open

Immunology

Oncology

IF: 5.1

Q1

Open

CG

Cancer Gene Therapy

Springer Nature

IF: 5

Q1

Hybrid

Genetics

Research

Oncology

IF: 5

Q1

Hybrid

IJ

International Journal Of Oncology

Spandidos Publishing

IF: 4.9

Q1

Open

Oncology

IF: 4.9

Q1

Open

IJ

International Journal Of Cancer

WILEY

IF: 4.7

Q1

Hybrid

Oncology

IF: 4.7

Q1

Hybrid

IJ

International Journal Of Gynecological Cancer

BMJ

IF: 4.7

Q1

Hybrid

OB/GYN

Oncology

IF: 4.7

Q1

Hybrid

CE

Clinical Epigenetics

BioMed Central

IF: 4.4

Q1

Open

Genetics

Oncology

IF: 4.4

Q1

Open

OO

Oral Oncology

Elsevier BV

IF: 3.9

Q1

Hybrid

Dentistry

Oncology

IF: 3.9

Q1

Hybrid

JC

Jto Clinical And Research Reports

Elsevier BV

IF: 3.5

Q2

Open

Oncology

Respiratory

IF: 3.5

Q2

Open

TL

Translational Lung Cancer Research

AME PUBLISHING COMPANY

IF: 3.5

Q2

Open

Oncology

Respiratory

IF: 3.5

Q2

Open

AO

Annals Of Surgical Oncology

Springer Science+Business Media

IF: 3.5

Q2

Hybrid

Oncology

Surgery

IF: 3.5

Q2

Hybrid

Ej

Ejso

Elsevier BV

IF: 2.9

Q2

Hybrid

Oncology

Surgery

IF: 2.9

Q2

Hybrid

EJ

European Journal Of Oncology Nursing

Elsevier BV

IF: 2.7

Q1

Hybrid

Nursing

Oncology

IF: 2.7

Q1

Hybrid

PC

Pigment Cell & Melanoma Research

WILEY

IF: 2.6

Q2

Hybrid

Dermatology

Oncology

IF: 2.6

Q2

Hybrid

CN

Cancer Nursing

LIPPINCOTT WILLIAMS & WILKINS

IF: 2.5

Q1

Closed

Nursing

Oncology

IF: 2.5

Q1

Closed

TC

Thoracic Cancer

WILEY

IF: 2.3

Q3

Open

Oncology

Respiratory

IF: 2.3

Q3

Open

JO

Journal Of Chemotherapy

Taylor & Francis

IF: 1.8

Q3

Hybrid

Infectious

Oncology

Pharmacology

IF: 1.8

Q3

Hybrid

AR

Anticancer Research

International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts

IF: 1.7

Q4

Closed

Oncology

IF: 1.7

Q4

Closed

AJ

American Journal Of Translational Research

e-Century Publishing Corporation

IF: 1.6

Q3

Open

Research

Oncology

IF: 1.6

Q3

Open